» Articles » PMID: 17512787

Effect of CPAP on QT Interval Dispersion in Obstructive Sleep Apnea Patients Without Hypertension

Overview
Journal Sleep Med
Specialties Neurology
Psychiatry
Date 2007 May 22
PMID 17512787
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: Delayed cardiac repolarization leading to prolongation of the QT interval is a well-characterised precursor of arrhythmias. Obstructive sleep apnea (OSA) might cause arrhythmias, since QT corrected interval dispersion (QTcd) is increased in these patients. We aimed to determine the effect of nasal continuous positive airway pressure (CPAP) therapy on QTcd in OSA patients without hypertension.

Methods: An overnight polysomnography (PSG) and a standard 12-lead electrocardiogram (ECG) were performed on 49 subjects without hypertension, diabetes mellitus, cardiac or pulmonary disease or any hormonal, hepatic, renal or electrolyte disorders. In 29 moderate-severe OSA (apnea-hypopnea index: AHI15) patients, QTd (defined as the difference between the maximum and minimum QT interval) and QTcd were calculated using the Bazzet formula at baseline and after six months of CPAP therapy.

Results: Eighteen patients were compliant with nasal CPAP, and mean age was 46.5+/-4.9 years. Patients had high body mass index (BMI: 30.6+/-4.0 kg/m(2)), but there was no change in either BMI or blood pressure after six months. A strong positive correlation was shown between QTcd and AHI (p<0.001, r=0.913). The QTcd at baseline (54.5+/-8.7 ms) significantly decreased after CPAP therapy (35.5+/-4.2 ms, p<0.001), although it did not significantly change in 11 non-compliant patients.

Conclusion: In OSA patients without hypertension, CPAP therapy improves the inhomogeneity of repolarization via a significant decrease in QTcd.

Citing Articles

Genetic QT score as a predictor of sudden cardiac death in participants with sleep-disordered breathing in the UK Biobank.

Arora A, Zareba W, Woosley R, Klimentidis Y, Patel I, Quan S J Clin Sleep Med. 2024; 21(3):549-557.

PMID: 39589075 PMC: 11874099. DOI: 10.5664/jcsm.11474.


Heart failure and central sleep apnea in the era of implantable recorders.

Cabac-Pogorevici I, Revenco V Anatol J Cardiol. 2021; 25(4):216-224.

PMID: 33830042 PMC: 8923486. DOI: 10.5152/AnatolJCardiol.2021.63668.


Correlation between apnea-hypopnea index and Tp-Te interval, Tp-Te/QT, and Tp-Te/QTc ratios in obstructive sleep apnea.

Karacop E, Karacop H Ann Noninvasive Electrocardiol. 2020; 26(2):e12809.

PMID: 33064338 PMC: 7935099. DOI: 10.1111/anec.12809.


Ventricular Arrhythmias in Patients with Obstructive Sleep Apnea.

Marinheiro R, Parreira L, Amador P, Mesquita D, Farinha J, Fonseca M Curr Cardiol Rev. 2018; 15(1):64-74.

PMID: 30338742 PMC: 6367697. DOI: 10.2174/1573403X14666181012153252.


Arrhythmogenic mechanisms of obstructive sleep apnea in heart failure patients.

Chadda K, Fazmin I, Ahmad S, Valli H, Edling C, Huang C Sleep. 2018; 41(9).

PMID: 30016501 PMC: 6132629. DOI: 10.1093/sleep/zsy136.